메뉴 건너뛰기




Volumn 27, Issue 1, 2017, Pages 44-50

Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin

Author keywords

Anemia; chronic kidney disease; hepcidin

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN A1C; HEPCIDIN; TRANSFERRIN;

EID: 85009083784     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.179301     Document Type: Article
Times cited : (6)

References (23)
  • 2
    • 80054849522 scopus 로고    scopus 로고
    • Efficacy and safety of continuous erythropoietin receptor activator (CERA)
    • Aggawal HK, Jain D, Verma K. Efficacy and safety of continuous erythropoietin receptor activator (CERA). Int J Pharm Pharm Sci 2011;3:292-6.
    • (2011) Int J Pharm Pharm Sci , vol.3 , pp. 292-296
    • Aggawal, H.K.1    Jain, D.2    Verma, K.3
  • 3
    • 84872790690 scopus 로고    scopus 로고
    • Chronic kidney disease
    • Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors 18th ed. New York: The McGraw Hill Companies, Inc.
    • Bargman JM, Skorecki K. Chronic kidney disease. In Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 18th ed. New York: The McGraw Hill Companies, Inc.; 2012.
    • (2012) Harrison's Principles of Internal Medicine
    • Bargman, J.M.1    Skorecki, K.2
  • 4
    • 70549093829 scopus 로고    scopus 로고
    • Inflammation and its impact on anaemia in chronic kidney disease: From haemoglobin variability to hyporesponsiveness
    • De Francisco AL, Stenvinkel P, Vaulont S. Inflammation and its impact on anaemia in chronic kidney disease: From haemoglobin variability to hyporesponsiveness. NDT Plus 2009;2 Suppl 1:i18-26.
    • (2009) NDT Plus , vol.2 , pp. i18-26
    • De Francisco, A.L.1    Stenvinkel, P.2    Vaulont, S.3
  • 5
    • 0036174760 scopus 로고    scopus 로고
    • Clinical factors influencing sensitivity and response to epoetin
    • Richardson D. Clinical factors influencing sensitivity and response to epoetin. Nephrol Dial Transplant 2002;17 Suppl 1:53-9.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 53-59
    • Richardson, D.1
  • 7
    • 84861154879 scopus 로고    scopus 로고
    • Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: A cross-sectional study
    • Uehata T, Tomosugi N, Shoji T, Sakaguchi Y, Suzuki A, Kaneko T, et al. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: A cross-sectional study. Nephrol Dial Transplant 2012;27:1076-83.
    • (2012) Nephrol Dial Transplant , vol.27 , pp. 1076-1083
    • Uehata, T.1    Tomosugi, N.2    Shoji, T.3    Sakaguchi, Y.4    Suzuki, A.5    Kaneko, T.6
  • 9
    • 10844258104 scopus 로고    scopus 로고
    • Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
    • Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
    • (2004) Science , vol.306 , pp. 2090-2093
    • Nemeth, E.1    Tuttle, M.S.2    Powelson, J.3    Vaughn, M.B.4    Donovan, A.5    Ward, D.M.6
  • 10
    • 33846650973 scopus 로고    scopus 로고
    • Molecular control of iron transport
    • Ganz T. Molecular control of iron transport. J Am Soc Nephrol 2007;18:394-400.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 394-400
    • Ganz, T.1
  • 11
    • 2342510407 scopus 로고    scopus 로고
    • IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
    • Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
    • (2004) J Clin Invest , vol.113 , pp. 1271-1276
    • Nemeth, E.1    Rivera, S.2    Gabayan, V.3    Keller, C.4    Taudorf, S.5    Pedersen, B.K.6
  • 12
    • 0035896581 scopus 로고    scopus 로고
    • A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload
    • Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-9.
    • (2001) J Biol Chem , vol.276 , pp. 7811-7819
    • Pigeon, C.1    Ilyin, G.2    Courselaud, B.3    Leroyer, P.4    Turlin, B.5    Brissot, P.6
  • 13
    • 33845245942 scopus 로고    scopus 로고
    • Suppression of hepcidin during anemia requires erythropoietic activity
    • Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006;108:3730-5.
    • (2006) Blood , vol.108 , pp. 3730-3735
    • Pak, M.1    Lopez, M.A.2    Gabayan, V.3    Ganz, T.4    Rivera, S.5
  • 14
    • 84903609037 scopus 로고    scopus 로고
    • The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease
    • Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, et al. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS One 2014;9:e99781.
    • (2014) PLoS One , vol.9 , pp. e99781
    • Mercadal, L.1    Metzger, M.2    Haymann, J.P.3    Thervet, E.4    Boffa, J.J.5    Flamant, M.6
  • 15
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39 2 Suppl 1:S1-266.
    • (2002) Am J Kidney Dis , vol.39 , Issue.2 , pp. S1-266
  • 16
    • 84884333035 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for anemia in chronic kidney disease
    • Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group.
    • Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012;2:279-335.
    • (2012) Kidney Int Suppl , vol.2 , pp. 279-335
  • 17
    • 33646345152 scopus 로고    scopus 로고
    • KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease
    • KDOQI; National Kidney Foundation
    • KDOQI; National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47 5 Suppl 3:S11-145.
    • (2006) Am J Kidney Dis , vol.47 , Issue.5 , pp. S11-145
  • 18
    • 77649206366 scopus 로고    scopus 로고
    • Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate
    • Peters HP, Laarakkers CM, Swinkels DW, Wetzels JF. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant 2010;25:848-53.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 848-853
    • Peters, H.P.1    Laarakkers, C.M.2    Swinkels, D.W.3    Wetzels, J.F.4
  • 19
    • 64949191416 scopus 로고    scopus 로고
    • Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
    • Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 2009;75:976-81.
    • (2009) Kidney Int , vol.75 , pp. 976-981
    • Ashby, D.R.1    Gale, D.P.2    Busbridge, M.3    Murphy, K.G.4    Duncan, N.D.5    Cairns, T.D.6
  • 21
    • 77957304252 scopus 로고    scopus 로고
    • Current status of the measurement of blood hepcidin levels in chronic kidney disease
    • Macdougall IC, Malyszko J, Hider RC, Bansal SS. Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol 2010;5:1681-9.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 1681-1689
    • Macdougall, I.C.1    Malyszko, J.2    Hider, R.C.3    Bansal, S.S.4
  • 22
    • 73149122764 scopus 로고    scopus 로고
    • Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization
    • Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization. Haematologica 2009;94:1748-52.
    • (2009) Haematologica , vol.94 , pp. 1748-1752
    • Kroot, J.J.1    Kemna, E.H.2    Bansal, S.S.3    Busbridge, M.4    Campostrini, N.5    Girelli, D.6
  • 23
    • 77957588960 scopus 로고    scopus 로고
    • Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients
    • Ford BA, Eby CS, Scott MG, Coyne DW. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients. Kidney Int 2010;78:769-73.
    • (2010) Kidney Int , vol.78 , pp. 769-773
    • Ford, B.A.1    Eby, C.S.2    Scott, M.G.3    Coyne, D.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.